Nyasha Sayi, a 31-year-old sex worker in Epworth on the outskirts of Harare, recently received her first lenacapavir injection. The shot is given twice a year and is part of a phase one rollout of the long-acting HIV prevention drug in Zimbabwe. Officials said at a 31 January meeting that an estimated 2,000 people have already received the injection.
The programme covers 11 sites nationwide and aims to reach about 46,000 people at high risk. It targets sex workers, men who have sex with men and other key populations. In February the US Ambassador announced a wind down of major US-supported health interventions, and a diplomatic dispute has since emerged.
Officials warn the dispute could put future doses at risk. Scientists say delays in follow-up injections might create drug resistance. Sayi said she is unsure whether she will get her next dose and that missing doses would put her at risk.
Difficult words
- rollout — the process of starting a new service
- phase — a separate stage in a processphase one
- prevention — actions to stop a disease or problem
- programme — an organised set of planned activities
- dispute — a disagreement between people or groups
- resistance — when a drug no longer works well
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- How would you feel if you were unsure about getting your next medical dose?
- Do you think health programmes should focus on people at high risk? Why or why not?
- Why might missing follow-up injections be a problem for a person?
Related articles
Vigorous exercise helps sleep in older adults with mild cognitive impairment
A small Texas A&M study used Oura Rings to track seven older adults with mild cognitive impairment for 14 days. Vigorous exercise gave the largest sleep benefit; light activity helped a little and moderate exercise showed no clear effect.
Emory study: 2023–24 COVID vaccine gives lasting antibodies
Emory University measured antibody responses in 24 people after the 2023–24 monovalent vaccine targeting Omicron XBB.1.5. The study found long-lasting antibodies, cross-reactive protection with the ancestral WA1 strain, and a 2.8-fold boost from immune imprinting.
Drugs against elephantiasis linked to fewer new HIV cases in Tanzania
A 12-year study in southwest Tanzania found that mass treatment for lymphatic filariasis (elephantiasis) was linked to fewer new HIV infections. Researchers say clearing the parasite may reduce HIV risk, but policies have not changed.